Injective Breaks Out as MACD Crossover Meets RWA Growth

Injective (INJ) has broken out of its prolonged accumulation phase, showing renewed bullish momentum. This is supported by a fresh MACD crossover, which JAVON MARKS notes could signal additional upside towards $60.

The token's price has surged from around $5 to over $8 in recent months, with the 20-day EMA at $6.06 serving as an important dynamic support zone during potential short-term pullbacks.

Injective is also expanding its real-world asset infrastructure, with a pilot project involving trade financing and AI-based financial operations. This includes tokenizing trade receivables and issuing compliant tokens, which could help achieve fast settlement and programmatic use cases for real-world assets.